Treatment of adult CRMO patients typically consists of NSAIDs as a first line therapy, and corticosteroids, methotrexate, sulfasalazine, bisphosphonates, anti-TNF-α, and anti-IL-1R agents with some variation dependent on a patient’s specific needs and medical history. Here, IL1R1 is linked to chronic recurrent multifocal osteomyelitis.